Immunosuppression in renal transplantation. Meta-analysis should not have included one of the studies
Morris-Stiff, G.; Khan, A.; Quiroga, I.; Baboo, R.; Jurewicz, W.A.
Bmj 319(7217): 1136; Author Reply 1137
1999
ISSN/ISBN: 0959-8138 PMID: 10531121 Document Number: 505248
Document emailed within 1 workday
Related Documents
Kawaguchi, H.; Komatsu, Y.; Hattori, M.; Nagata, M.; Ito, K.; Takahashi, K.; Teraoka, S.; Toma, H.; Ota, K. 1989: Somatic growth and renal function in pediatric renal transplantation with alternate-day steroid immunosuppression using cyclosporine (CsA) in Japan Transplantation Proceedings 21(1 Part 2): 1698-1700Rosa, M.Inês.; Madeira, K.; Medeiros, L.Rosi. 2013: Can a meta-analysis that included articles with high heterogeneity appropriately evaluate the risk of venous thromboembolism in users of combined hormonal contraceptives containing drospirenone or desogestrel? European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 18(2): 137-139
Rosa, M.Inês.; Madeira, K.; Medeiros, L.Rosi. 2013: Can a meta-analysis that included articles with high heterogeneity appropriately evaluate the risk of venous thromboembolism in users of combined hormonal contraceptives containing drospirenone or desogestrel? European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 18(2): 137-139
Bonomini, V.; Scolari, M.P.; Buscaroli, A.; Liviano D'Arcangelo, G.; Stefoni, S. 1997: Immunosuppression in renal transplantation International Journal of Artificial Organs 20(2): 73-75
Tax, W.J.; van de Heijden, H.M.; Willems, H.W.; Hoitsma, A.J.; Berden, J.H.; Capel, P.J.; Koene, R.A. 1987: Immunosuppression with monoclonal anti-T3 antibody (WT32) in renal transplantation Transplantation Proceedings 19(1 Part 3): 1905-1907
Raine, A.E.; Carter, R.; Mann, J.I.; Chapman, J.R.; Morris, P.J. 1987: Increased plasma LDL cholesterol after renal transplantation associated with cyclosporine immunosuppression Transplantation Proceedings 19(1 Part 2): 1820-1821
Tanabe, K.; Koga, S.; Takahashi, K.; Sonda, K.; Tokumoto, T.; Babazono, T.; Yagisawa, T.; Toma, H.; Kawai, T.; Fuchinoue, S.; Teraoka, S.; Ota, K. 1996: Diabetes mellitus after renal transplantation under FK 506 (tacrolimus) as primary immunosuppression Transplantation Proceedings 28(3): 1304-1305
Odocha, O.; McCauley, J.; Scantlebury, V.; Shapiro, R.; Carroll, P.; Jordan, M.; Vivas, C.; Fung, J.J.; Starzl, T.E. 1993: Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression Transplantation Proceedings 25(4): 2433-2434
Schweizer, R.T.; Bow, L.; Roper, L.; Hull, D.; Bartus, S.A. 1988: Renal transplantation at Hartford Hospital: results of combined and flexible immunosuppression Clinical Transplants 1988: 147-158
Andreu, J.; Campistol, J.M.; Oppenheimer, F.; Torregrosa, V.; Ricart, M.J.; Vilardell, J.; Carretero, P. 1994: Cyclosporine monotherapy as primary immunosuppression in renal transplantation--five-year experience Transplantation Proceedings 26(1): 337-340
Shabtai, M.; Anaise, D.; Frei, L.; Waltzer, W.C.; Frischer, Z.I.; Jao, S.; Miller, F.; Rapaport, F.T. 1989: Malakoplakia in renal transplantation: an expression of altered tissue reactivity under immunosuppression Transplantation Proceedings 21(4): 3725-3727
Tinti, F.; Mitterhofer, A.P.; Muiesan, P. 2012: Liver transplantation: role of immunosuppression, renal dysfunction and cardiovascular risk factors Minerva Chirurgica 67(1): 1-13
Norman, D.J.; Barry, J.M.; Bennett, W.M.; Munson, J.L.; Meyer, M.; Henell, K.; Kimball, J.; Hubert, B. 1991: OKT3 for induction immunosuppression in renal transplantation: a comparative study of high versus low doses Transplantation Proceedings 23(1 Part 2): 1052-1054
Goffin, E.; Devogelaer, J.P.; Depresseux, G.; Squifflet, J.P.; Pirson, Y.; van Yperselede de Strihou, C. 2003: Evaluation of bone mineral density after renal transplantation under a tacrolimus-based immunosuppression: a pilot study Clinical Nephrology 59(3): 190-195
Rao, K.V.; Andersen, R.C. 1989: The impact of quadruple versus triple drug immunosuppression on clinical results of cadaver renal transplantation Transplantation Proceedings 21(1 Part 2): 1652
Graves, N.; Walker, D.; Raine, R.; Hutchings, A.; Roberts, J.A. 2002: Cost data for individual patients included in clinical studies: no amount of statistical analysis can compensate for inadequate costing methods Health Economics 11(8): 735-739
Tsai, M.-K.; Hu, R.-H.; Lee, C.-J.; Lee, P.-H. 2002: Efficacy of low-dose mycophenolate mofetil therapy for Taiwanese renal transplantation patients receiving primary cyclosporine immunosuppression Journal of the Formosan Medical Association 101(9): 616-621
Cook, D.J.; Guyatt, G.H.; Ryan, G.; Clifton, J.; Buckingham, L.; Willan, A.; McIlroy, W.; Oxman, A.D. 1993: Should unpublished data be included in meta-analyses? Current convictions and controversies JAMA 269(21): 2749-2753
Graudal, N.A.; Galløe, A.M.; Storm, T.L. 1991: Effect of salt-restriction on blood pressure. A review over epidemiological studies and a meta-analysis of clinically controlled studies Ugeskrift for Laeger 153(27): 1914-1920
Berhan, Y.; Berhan, A. 2014: A meta-analysis of socio-demographic factors for perinatal mortality in developing countries: a subgroup analysis of the national surveys and small scale studies Ethiopian Journal of Health Sciences 24 Suppl: 41-54